In Episode 4 of Season 5 of the Expand Podcast, we sit down with Shanta Zurock, a clinical pharmacist and healthcare access expert, to explore the complex system challenges surrounding Alpha-1 Antitrypsin Deficiency (AATD) in Canada.Drawing from decades of experience in pharmaceutical care, Ms. Zurock offers a behind-the-scenes look at drug access, insurance navigation, and policy barriers that affect patients with rare diseases like AATD. This episode is a must-listen for healthcare professionals, advocates, and patients seeking to understand how the system works—and how to make it better.👇 Learn more and explore additional resources:🔹 Episode recap and resources https://chroniclungdiseases.com/en/news/understanding-patient-support-programs-in-alpha-1/🔹 Living Well with COPD – AATD Module (free) https://chroniclungdiseases.com/register🔹 Canadian Thoracic Society AATD Guidelines https://www.tandfonline.com/doi/full/10.1080/24745332.2024.2443178🔹 Learn more about Season 5 https://chroniclungdiseases.com/en/the-expand-podcast-season-5-aatd/🔹 Watch more episodes about Alpha-1 https://www.youtube.com/playlist?list=PLKERLVA6ikI5X8SabIgyphzutdp8RyKUBThis podcast is produced by RESPIPLUS™ with support from Takeda Canada to raise awareness about Alpha-1 and improve access to care across Canada.The eXpand Podcast episodes are available in english and french or with french subtitles available in the english version.Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube• Apple Podcast: https://bit.ly/eXpandPodcastApple• Spotify: https://bit.ly/eXpandPodcastSpotify• Google Podcasts: https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #alpha1 #aatdAlpha-1 antitrypsin deficiency, lung disease, patient advocacy, augmentation therapy, healthcare access, chronic obstructive pulmonary disease, genetic conditions, awareness, diagnosis, treatment